DAPK Inhibitors
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
[4-[[5-Chloro-4-(methylamino)-2-pyrimidinyl]amino]-3-methoxyphenyl]-4-morpholinylmethanone | 1351758-81-0 | sc-505086 | 100 mg | $11500.00 | ||
This compound is a potent and selective inhibitor of Death-associated protein kinase (DAPK) family members. It has demonstrated the ability to interfere with Death-associated protein kinase (DAPK)-mediated signaling pathways, making it a valuable tool for studying the functions of these kinases. | ||||||
STO-609 | 52029-86-4 | sc-507444 | 5 mg | $140.00 | ||
While primarily known as a CaMKK inhibitor, STO-609 has also been shown to inhibit Death-associated protein kinases. It interferes with the interaction between Death-associated protein kinase (DAPK) and its binding partner, enabling researchers to explore DAPK-related processes. | ||||||
BML-275 | 866405-64-3 | sc-200689 sc-200689A | 5 mg 25 mg | $94.00 $348.00 | 69 | |
Although primarily known as an AMP-activated protein kinase (AMPK) inhibitor, Compound C has also been reported to inhibit DAPKs. | ||||||
AZD7762 | 860352-01-8 | sc-364423 | 2 mg | $107.00 | ||
While primarily known as a checkpoint kinase 1 (Chk1) inhibitor, AZD7762 has been reported to have inhibitory effects on DAPKs. Its kinase-targeting profile adds to its potential utility. | ||||||
LDN-214117 | 1627503-67-6 | sc-507451 | 5 mg | $165.00 | ||
LDN-214117 has been identified as a dual inhibitor of multiple kinases, including DAPKs. Its effects on kinase signaling offer opportunities to investigate DAPK functions. | ||||||
Selumetinib | 606143-52-6 | sc-364613 sc-364613A sc-364613B sc-364613C sc-364613D | 5 mg 10 mg 100 mg 500 mg 1 g | $28.00 $80.00 $412.00 $1860.00 $2962.00 | 5 | |
Originally developed as a MEK inhibitor, it has been found to have inhibitory effects on DAPK. | ||||||
Roscovitine | 186692-46-6 | sc-24002 sc-24002A | 1 mg 5 mg | $92.00 $260.00 | 42 | |
A cyclin-dependent kinase (CDK) inhibitor with broad activity, including inhibition of DAPK. | ||||||
Harmine | 442-51-3 | sc-202644 sc-202644A sc-202644B sc-202644C sc-202644D sc-202644E sc-202644F | 250 mg 500 mg 1 g 10 g 50 g 100 g 500 g | $52.00 $102.00 $124.00 $540.00 $1438.00 $2560.00 $11230.00 | 2 | |
An alkaloid with various pharmacological activities, including inhibition of DAPK. | ||||||
NH125 | 278603-08-0 | sc-203037 | 5 mg | $187.00 | 1 | |
Originally identified as a eukaryotic elongation factor-2 kinase inhibitor, it also exhibits inhibitory effects on DAPK. | ||||||